Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Katayama

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Scandinavian Journal of Urology|February 10, 2022
Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysisSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
World Journal of Urology|May 17, 2021
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomyPawel Rajwa, Victor M Schuettfort, Fahad Quhal, et al.
Urologic Oncology|October 8, 2024
The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysisIchiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
Clinical Genitourinary Cancer|November 15, 2024
The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Japanese Journal of Clinical Oncology|October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
European Urology Focus|March 25, 2021
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease RecurrenceEkaterina Laukhtina, Mohammad Abufaraj, Abdallah Al-Ani, et al.
BMC Urology|April 28, 2025
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Nutrition and Cancer|July 3, 2026
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective StudyRyutaro Shimizu, Shuichi Morizane, Noriya Yamaguchi, et al.
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Scandinavian Journal of Urology|February 10, 2022
Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysisSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
World Journal of Urology|May 17, 2021
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomyPawel Rajwa, Victor M Schuettfort, Fahad Quhal, et al.
Urologic Oncology|October 8, 2024
The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysisIchiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
Clinical Genitourinary Cancer|November 15, 2024
The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Japanese Journal of Clinical Oncology|October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
European Urology Focus|March 25, 2021
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease RecurrenceEkaterina Laukhtina, Mohammad Abufaraj, Abdallah Al-Ani, et al.
BMC Urology|April 28, 2025
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysisIchiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, et al.
Nutrition and Cancer|July 3, 2026
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective StudyRyutaro Shimizu, Shuichi Morizane, Noriya Yamaguchi, et al.
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Pageof 15